MINNEAPOLIS, July 23, 2014 /PRNewswire/ --
Core MRI technology provides most advanced scanners for
highest intraoperative image quality and best workflow
available
IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company")
today announced that the Company has obtained regulatory CE mark
for integrating the next generation MRI core technology into the
VISIUS® Surgical Theatre, allowing for sales and
marketing in the European Union.
This newest imaging technology, based on the Siemens Aera
1.5T(tesla) and Skyra 3.0T MRI scanners, helps IMRIS deliver even
better image quality, faster 3D image acquisition, and improved
ease-of-use and workflow during surgical procedures using
intraoperative MRI (iMRI). The Company received United States Food
and Drug Administration (FDA) approval for these advancements in
February 2014.
"These high-field intraoperative scanner options will give a
hospital's clinical team state-of-the-art applications and image
quality that increase productivity," said IMRIS President and CEO
Jay D. Miller. "We bring the latest
and unequaled imaging technology into the operating room where it
can make the most difference - during the surgery. More and more
neurosurgical centers are using image guidance with VISIUS iMRI for
an expanding list of conditions and procedures and adjunctive
interventions beyond brain tumor resections, such as laser ablation
for tumors and epilepsy using stereotactic tools, deep brain
stimulation (DBS) and other minimally-invasive techniques that are
designed to improve patient outcomes."
Inside a VISIUS Surgical Theatre equipped with high-field iMRI,
surgeons have on-demand access to real-time data and
state-of-the-art imaging during the procedure as the scanner
uniquely moves on ceiling-mounted rails. The Company also designs
and manufactures proprietary intraoperative CTs, head fixation
devices, imaging coils, and OR tables for use in this unique and
multifunctional intraoperative environment.
About IMRIS
IMRIS (NASDAQ: IMRS; TSX: IM) is a
global leader in providing image guided therapy solutions through
its VISIUS Surgical Theatre - a revolutionary, multifunctional
surgical environment that provides unmatched intraoperative vision
to clinicians to assist in decision making and enhance precision in
treatment. The multi-room suites incorporate diagnostic quality
high-field MR, CT and angio modalities accessed effortlessly in the
operating room setting. VISIUS Surgical Theatres serve the
neurosurgical, spinal, cardiovascular and cerebrovascular markets
and have been selected by 58 leading medical institutions around
the world.
Image with caption: "The IMRIS VISIUS Surgical Theatre with
intraoperative MRI (iMRI) has received CE mark for European
distribution for including Siemens Aera and Skyra MR technology.
This provides neurosurgeons using the system with the most advanced
MR scanners for the highest intraoperative image quality and
workflow in an operating room. (CNW Group/IMRIS Inc.)". Image
available at:
http://photos.newswire.ca/images/download/20140723_C8482_PHOTO_EN_42224.jpg
For further information:
Kevin J. Berger
Marketing Communications Manager
IMRIS, Inc.
Tel: +1-763-203-6332
Email: kberger@imris.com